Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro
AUTOR(ES)
Bellagamba, Bruno Corrêa, Abreu, Bianca Regina Ribas de, Grivicich, Ivana, Markarian, Carolina Franke, Chem, Eduardo, Camassola, Melissa, Nardi, Nance Beyer, Dihl, Rafael Rodrigues
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
2016-03
RESUMO
Abstract Mesenchymal stem cells (MSCs) are known for their important properties involving multilineage differentiation potential., trophic factor secretion and localization along various organs and tissues. On the dark side, MSCs play a distinguished role in tumor microenvironments by differentiating into tumor-associated fibroblasts or supporting tumor growth via distinct mechanisms. Cisplatin (CIS) is a drug widely applied in the treatment of a large number of cancers and is known for its cytotoxic and genotoxic effects, both in vitro and in vivo. Here we assessed the effects of CIS on MSCs and the ovarian cancer cell line OVCAR-3, by MTT and comet assays. Our results demonstrated the resistance of MSCs to cell death and DNA damage induction by CIS, which was not observed when OVCAR-3 cells were exposed to this drug.
Documentos Relacionados
- In vitro cytotoxic, genotoxic and antioxidant/oxidant effects of guaiazulene on human lymphocytes
- Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues
- Effects of Human Umbilical Cord Mesenchymal Stem Cells on Renal Ischaemia-reperfusion Injury in Rats
- In vitro cytotoxic and non-genotoxic effects of gutta-percha solvents on mouse lymphoma cells by single cell gel (comet) assay
- Adhesion to Vitronectin and Collagen I Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells